Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

NCT04665323 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT04665323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04665323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
January 18, 2021
Completion date
April 30, 2021
Enrollment
411 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrodysplasia ossificans progressiva